Skip to content

Comparison of the effectiveness of cognitive-behavioral therapy and motivational interviewing on the symptoms of anxiety sensitivity, depression and self-esteem in divorced women

Comparison of the effectiveness of cognitive-behavioral therapy and motivational interviewing on the symptoms of anxiety sensitivity, depression and self-esteem in divorced women covered by comprehensive health service centers in Khomein city.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220328054360N1
Enrollment
60
Registered
2022-04-18
Start date
2022-04-21
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depressive disorder. Condition 2: anxiety sensitivity. Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified

Interventions

Intervention 1: Intervention group: Cognitive-behavioral therapy: A type of psychotherapy that helps patients understand the thoughts and feelings that affect behaviors. Cognitive-behavioral therapy i

Sponsors

Khomein School of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: The borderline score in the Rosenberg Self-Esteem Questionnaire is 10 questions, 30 and below The borderline score in the Anxiety Sensitivity Questionnaire is 25 and higher The borderline score in the Anxiety Sensitivity Questionnaire is 25 Absence of psychotic and paranoid disorders in the subjects Receiving voluntary and informed consent At least 6 months have passed since their divorce Age gap between 20 to 50 years Have at least a diploma

Exclusion criteria

Exclusion criteria: Absence for more than two sessions Lack of interest of people to continue education

Design outcomes

Primary

MeasureTime frame
The primary outcome is the "Depression Score in the Beck Questionnaire".For this purpose, achieving the differential rate of depression between the two depressed and healthy groups, number 17, is determined, which is the appropriate number of differentiation between this group. Timepoint: Experimental groups undergo motivational interview therapy for 5 sessions of 75 minutes and cognitive-behavioral therapy for 12 sessions of 75 minutes from May 1401, one session per week until the end of July. Method of measurement: The research instrument is Aaron Beck, Beckward, Mendelson, Mark and Arbaf (1986) Depression Scale Questionnaire.;The primary outcome is the anxiety sensitivity score obtained in the Anxiety Sensitivity Questionnaire. In this questionnaire, the highest score that a person can get is 80 and the lowest score is 16. A high score close to 80 will mean that the person has a high anxiety sensitivity, and a low score on this test will mean that the person is experiencing a low anxiety sensitivity. The borderline score is 25 or higher. Timepoint: Experimental groups undergo motivational interview therapy for 5 sessions of 75 minutes and cognitive-behavioral therapy for 12 sessions of 75 minutes from May 1401, one session per week until the end of July. Method of measurement: Research tool Anxiety Sensitivity Questionnaire: is a self-report questionnaire that has 16 items. This questionnaire was developed by Reese and Patterson (1985).;The primary outcome is the self-esteem score obtained on the Rosenberg Self-Esteem Questionnaire. This scale contains 10 general terms that measure life satisfaction and feeling good about oneself. Timepoint: Experimental groups undergo motivational interview therapy for 5 sessions of 75 minutes and cognitive-behavioral therapy for 12 sessions of 75 minutes from May 1401, one session per week until the end of July. Method of measurement: The research tool is the Rosenberg Self-Esteem Scale Questionnaire, which consists of 10 items

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Bayatasghari

Khomein School of Medical ScieKhomein School of Medical Sciencesnces

abolfazl86khomein@yahoo.com+98 86 4622 9237

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026